Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/2012 → 30/06/2017 |
Collaborative partners
- King's College London
- King's College London (KCL) (lead)
Funding
- EC European Commission: £709,703.00
A European multicentre double-blind plaebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer's disease NILVAD
- Howard, Robert (Primary Investigator)
- Murphy, Caroline (Co-Investigator)
Project: Research